🇺🇸 FDA
Pipeline program

Toripalimab + Chemotherapy

ChestMate-001(FK-NEO-TET-001)

Phase 2 small_molecule active

Quick answer

Toripalimab + Chemotherapy for Thymic Epithelial Tumor is a Phase 2 program (small_molecule) at Xiyuan Hospital of China Academy of Chinese Medical Sciences with 1 ClinicalTrials.gov record(s).

Program details

Company
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Indication
Thymic Epithelial Tumor
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials